Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_assertion type Assertion NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_head.
- NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_provenance.
- NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_assertion evidence source_evidence_literature NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_provenance.
- NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_assertion SIO_000772 15709193 NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_provenance.
- NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_assertion wasDerivedFrom gad-20150221 NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_provenance.
- NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_assertion wasGeneratedBy ECO_0000203 NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_provenance.